UBS Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57.3M | Buy |
|
|||||
|
2025
Q2 | $16.9M | Sell |
|
|||||
|
2025
Q1 | $17.7M | Buy |
|
|||||
|
2024
Q4 | $5.99M | Buy |
|
|||||
|
2024
Q3 | $8.17M | Buy |
|
|||||
|
2024
Q2 | $4.26M | Sell |
|
|||||
|
2024
Q1 | $4.99M | Buy |
|
|||||
|
2023
Q4 | $1.76M | Buy |
|
|||||
|
2023
Q3 | $740K | Sell |
|
|||||
|
2023
Q2 | $2.03M | Buy |
|
|||||
|
2023
Q1 | $1.25M | Sell |
|
|||||
|
2022
Q4 | $3.66M | Buy |
|
|||||
|
2022
Q3 | $455K | Sell |
|
|||||
|
2022
Q2 | $597K | Sell |
|
|||||
|
2022
Q1 | $1.68M | Buy |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $928K | Buy |
|
|||||
|
2021
Q2 | $94K | Sell |
|
|||||
|
2021
Q1 | $673K | Buy |
|
|||||
|
2020
Q4 | $49K | Buy |
|